This is a Validated Antibody Database (VAD) review about human IL13RA2, based on 3 published articles (read how Labome selects the articles), using IL13RA2 antibody in all methods. It is aimed to help Labome visitors find the most suited IL13RA2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL13RA2 synonym: CD213A2; CT19; IL-13R; IL13BP; interleukin-13 receptor subunit alpha-2; IL-13 receptor subunit alpha-2; IL-13R subunit alpha-2; IL-13R-alpha-2; IL-13RA2; cancer/testis antigen 19; interleukin 13 binding protein; interleukin 13 receptor alpha 2 chain; interleukin 13 receptor, alpha 2

Abcam
mouse monoclonal
  • immunohistochemistry; human; 1:500
Abcam IL13RA2 antibody (Abcam, ab55275) was used in immunohistochemistry on human samples at 1:500. J Clin Oncol (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (B-D13)
  • immunocytochemistry; human
Santa Cruz Biotechnology IL13RA2 antibody (Santa Cruz Biotechnology, 2 B-D13) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
Proteintech Group
rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 4a
Proteintech Group IL13RA2 antibody (Proteintech, 11059-1-AP) was used in immunohistochemistry on human samples at 1:100 (fig 4a). Front Neurosci (2015) ncbi
Articles Reviewed
  1. Brøchner C, Holst C, Møllgård K. Outer brain barriers in rat and human development. Front Neurosci. 2015;9:75 pubmed publisher
  2. Pollack I, Jakacki R, Butterfield L, Hamilton R, Panigrahy A, Potter D, et al. Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem . J Clin Oncol. 2014;32:2050-8 pubmed publisher
  3. Volonté A, Di Tomaso T, Spinelli M, Todaro M, Sanvito F, Albarello L, et al. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4. J Immunol. 2014;192:523-32 pubmed publisher